Digestive and Intestinal Remedies Market Report 2026

Digestive and Intestinal Remedies Market Overview

• Digestive and Intestinal Remedies market size has reached to $22.28 billion in 2025 • Expected to grow to $30.43 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: The Rise In Gastrointestinal Disorder Cases Fuels Growth In The Digestive And Intestinal Remedy Market • Market Trend: Innovative Digital Platforms And Breath Testing For Personalized Gut Microbiome Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Digestive and Intestinal Remedies Market?

The digestive and intestinal remedy refers to medications that can treat gastrointestinal disorders such as stomach upset, constipation, and diarrhea. It uses classes of drugs such as antacids, proton pump inhibitors, and histamine2 blockers during the treatment process. The main types of digestive and intestinal remedies are digestive medicines, remedies against gastrointestinal complaints, and natural and synthetic agents. Digestive medicines consist of digestive enzymes, which are organic compounds required by the body to aid in the breakdown and digestion of meals. Digestive medicine helps treat occasional heartburn, nausea, and upset stomach. These are used by different age group such as pediatric, adults, and sold through various distribution channel such as online and offline.

What Is The Digestive and Intestinal Remedies Market Growth Forecast?

The digestive and intestinal remedies market size is expected to see strong growth in the next few years. It will grow to $30.43 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to advancements in gut microbiome therapies, integration of ai in digestive health diagnostics, growth of personalized nutrition and supplements, expansion of online pharmaceutical platforms, rising geriatric population with digestive issues. Major trends in the forecast period include personalized digestive health solutions, growth in herbal and natural remedies, increased focus on gut microbiome research, expansion of online pharmacy and e-pharmacy channels, rising awareness of preventive gastrointestinal care.

Global Digestive and Intestinal Remedies Market Segmentation

1) By Type: Digestive Medicines, Remedies Against Gastrointestinal Complaints, Natural And Synthetic Agents 2) By Age Group: Pediatric, Adults 3) By Distribution Channel: Online, Offline Subsegments: 1) By Digestive Medicines: Antacids, Digestive Enzymes, Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists 2) By Remedies Against Gastrointestinal Complaints: Anti-Nausea Medications, Antidiarrheal Agents, Laxatives, Gastroprotective Agents 3) By Natural And Synthetic Agents: Herbal Remedies, Synthetic Antispasmodics, Probiotics And Prebiotics

What Is The Driver Of The Digestive and Intestinal Remedies Market?

The increase in gastrointestinal disorder cases is expected to propel the digestive and intestinal remedy market going forward. Gastrointestinal disorders refer to a collective term of diseases such as nausea, vomiting, food poisoning, and diarrhea that impact the overall biological functioning of the gastrointestinal (GI) tract. The rising incidence of gastrointestinal disorders has resulted in a growing demand for digestive and intestinal remedies that can treat gastrointestinal diseases effectively. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization, approximately 26,890 new cases of stomach cancer are anticipated in the U.S. in 2024, with 16,160 cases in men and 10,730 in women, leading to about 10,880 deaths, comprising 6,490 men and 4,390 women. Therefore, an increase in gastrointestinal disorder cases is expected to drive the growth of the digestive and intestinal remedy market.

Key Players In The Global Digestive and Intestinal Remedies Market

Major companies operating in the digestive and intestinal remedies market are Bayer AG, Abbott Laboratories, Bausch Health Companies Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Jiangzhong Pharmaceutical Co. Ltd., Johnson & Johnson Pvt. Ltd., Menarini Group, Merck Co. & KGaA, Pfizer Inc., Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited, AbbVie Inc., Alfa Wassermann and Sigma-Tau, Allergan PLC, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Daiichi Sankyo Chemical Pharma Co. Ltd., Evoke Pharma Inc., Ipsen SA, Ironwood Pharmaceuticals Inc., Mundipharma, Mylan NV, Norgine Pharmaceuticals Ltd., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Perrigo Company, Recordati S.p.A., RedHill Biopharma Ltd., Ritter Pharmaceuticals Inc., Salix Pharmaceuticals Inc.

Global Digestive and Intestinal Remedies Market Trends and Insights

Major companies operating in the digestive and intestinal remedy market are developing innovative products such as digital platforms to meet larger customer bases, more sales, and increase revenue. Digital platforms refer to online technology-based systems or frameworks that enable the creation, delivery, and interaction of digital content, services, or products. For instance, in April 2023, Owlstone Medical, a UK-based biotechnology company, launched OMED Health, to empower patients to comprehend their gut microbiome and effectively oversee their digestive well-being. Initially concentrating on digestive ailments, OMED Health seeks to enhance the quality of life for individuals grappling with gut health issues by providing improved and expedited comprehension and control of their conditions. Within the realm of digestive health, the utilization of breath testing is emerging as an efficacious method for patients to monitor and regulate symptoms. The distinctive aspect of OMED Health's gut health tests lies in their ability to detect minute quantities of hydrogen and methane gases in breath, offering a convenient at-home collection process. These gases serve as crucial indicators of gut health, signaling specific conditions and diseases.

What Are Latest Mergers And Acquisitions In The Digestive and Intestinal Remedies Market?

In May 2023, Ironwood Pharmaceuticals, a US- and Switzerland-based company focused on gastrointestinal (GI) healthcare (notably commercializing Linzess for IBS), acquired VectivBio Holding AG for an undisclosed amount. With this acquisition, Ironwood aimed to strengthen its rare-GI disease pipeline, especially by adding apraglutide, a next-generation, long-acting GLP-2 analogue in Phase III for short bowel syndrome with intestinal failure (SBS-IF). VectivBio, a Switzerland-based biotechnology company specializing in regenerative medicine and rare disease therapies.

Regional Insights

North America was the largest region in the digestive and intestinal remedies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Digestive and Intestinal Remedies Market?

The digestive and intestinal remedies market consists of sales of antacids, prokinetic agents, laxatives, antidiarrheal agents, generic enzymes. Values in this market are ""factory gate"" values that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Digestive and Intestinal Remedies Market Report 2026?

The digestive and intestinal remedies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digestive and intestinal remedies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.